Factors associated with assertiveness among Japanese community pharmacists: a cross-sectional study [0.03%]
日本社区药剂师果断性的相关因素：一项横断面研究
Mitsuaki Ishii,Sachiko Ozone,Shoichi Masumoto et al.
Mitsuaki Ishii et al.
Background: Community pharmacists play a crucial role in promoting medication safety within the community healthcare team. Effective communication by community pharmacists with other health professionals is essential to f...
Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report [0.03%]
恩昔特韦与他克莫司在治疗新冠患者中的药物相互作用：一例报告
Yuki Miyata,Ryo Yamaguchi,Takehito Yamamoto et al.
Yuki Miyata et al.
Background: Ensitrelvir is a novel SARS-CoV-2 3-chymotrypsin-like protease inhibitor, similar to nirmatrelvir/ritonavir. Several case reports have demonstrated the efficacy of 3-chymotrypsin-like protease inhibitors in tr...
Correction: Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic [0.03%]
订正：新冠肺炎疫情期间营养支持团队活动额外医疗费用的有无设施比较
Akihiko Futamura,Takenao Koseki,Junichi Iida et al.
Akihiko Futamura et al.
Comparison of continuous subcutaneous hydromorphone hydrochloride and morphine hydrochloride injection on skin disorders incidence: a retrospective study [0.03%]
盐酸羟考酮与盐酸吗啡皮下连续输注皮肤反应发生率的回顾性研究
Rei Tanaka,Takahiro Hashizume,Tadashi Hisanaga et al.
Rei Tanaka et al.
Background: Continuous subcutaneous administration of injectable opioids is simple and effective; however, skin disorders may occur when high opioid dosages are used. Therefore, we investigated opioid injection drugs with...
Effect of changes in skin properties due to diabetes mellitus on the titration period of transdermal fentanyl: single-center retrospective study and diabetic animal model study [0.03%]
糖尿病引起皮肤性质变化对透皮芬太尼滴定周期影响的单中心回顾性研究及糖尿病动物模型研究
Satoshi Mizuno,Makiko Takabayashi,Hiroko Makihara et al.
Satoshi Mizuno et al.
Background: In the dose titration of transdermal fentanyl to prevent unrelieved pain, it is important to consider not only dose adjustment, but also the titration period, which is influenced by the time required to reach ...
Clinical characteristics of patients requiring emergency hospitalization due to immune-related adverse events: a retrospective study [0.03%]
基于免疫相关不良事件急诊住院患者的临床特征回顾性研究
Tatsuki Ikeda,Satoru Nihei,Kazuki Saito et al.
Tatsuki Ikeda et al.
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, offering hope for various malignancies by enhancing the immune response against tumors. However, ICIs are associated with unique immune...
Safety of talimogene laherparepvec: a real-world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS) [0.03%]
基于美国食品药品监督管理局不良事件报告系统(FDA FAERS)的塔利莫妥欣拉赫派尔肽疫苗(talimogene laherparepvec)安全性真实世界回顾性药物流行病学研究
Yifan Hong,Kebin Cheng,Han Qu et al.
Yifan Hong et al.
Background: Oncolytic virus therapy is a rapidly evolving emerging approach for the medical management of cancer. Talimogene laherparepvec (T-VEC) is the first and only Food and Drug Administration (FDA)-approved oncolyti...
Pharmacist intervention and identification of adverse events related to treatment efficacy in cancer chemotherapy to improve clinical outcomes [0.03%]
药学干预及识别癌症化疗相关治疗效益不良事件以改善临床预后
Hironori Fujii
Hironori Fujii
Adverse events (AEs) induced by cancer chemotherapy reduce not only patient quality of life (QOL) but also the efficacy of treatment. Management of AEs can therefore improve both the efficacy and safety of cancer chemotherapy. This review d...
Impact of pharmacist-led aminoglycoside stewardship: a 10-year observational study [0.03%]
基于药剂师的氨基糖苷类药物管理干预的效果分析——一项为期十年的观察性研究
Yasutaka Shinoda,Kengo Ohashi,Tomoko Matsuoka et al.
Yasutaka Shinoda et al.
Background: Aminoglycosides are crucial for treating multidrug-resistant gram-negative infections and endocarditis. However, aminoglycosides are associated with significant risks of nephrotoxicity, necessitating careful d...
The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study [0.03%]
联合应用氯吡格雷和阿司匹林时加用质子泵抑制剂与上消化道出血风险：一项回顾性单中心研究
Yutaro Ide,Go Morikawa,Kyohei Yoshida et al.
Yutaro Ide et al.
Objective: Dual-antiplatelet therapy (DAPT) and proton pump inhibitor (PPI) are frequently prescribed after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) placement. However, studies that evaluate...